• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

131碘单光子发射计算机断层扫描/计算机断层扫描(I-131 SPECT/CT)、氟代脱氧葡萄糖(F-FDG)及镓标记的成纤维细胞激活蛋白抑制剂04正电子发射断层扫描/计算机断层扫描(Ga-FAPI-04 PET/CT)成像在接受放射性碘治疗的转移性乳头状甲状腺癌患者中的研究结果

Findings of I-131 SPECT/CT, F-FDG, and Ga-FAPI-04 PET/CT Imaging in a Patient Treated with Radioiodine Therapy for Metastatic Papillary Thyroid Carcinoma.

作者信息

Tatar Gamze, Alçın Göksel, Erol Fenercioğlu Özge, Şahin Rahime, Çermik Tevfik Fikret

机构信息

University of Health Sciences Turkey, İstanbul Bağcılar Training and Research Hospital, Clinic of Nuclear Medicine, İstanbul, Turkey.

University of Health Sciences Turkey, İstanbul Training and Research Hospital, Clinic of Nuclear Medicine, İstanbul, Turkey.

出版信息

Mol Imaging Radionucl Ther. 2023 Feb 23;32(1):57-61. doi: 10.4274/mirt.galenos.2022.02438.

DOI:10.4274/mirt.galenos.2022.02438
PMID:36819619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9950682/
Abstract

A 50-year-old man undergone total thyroidectomy and histopathology revealed papillary thyroid carcinoma with a tumor size of 4.5 cm. The patient was referred to a nuclear medicine clinic for radioiodine therapy. Since the thyroglobulin level before the treatment was 495 ug/L, low-dose (185 MBq) I-131 scan was performed. In addition to multiple liver metastases, bone metastases were detected in the sacrum and right 7 rib in I-131 whole body scanning and single photon emission computed tomography/computed tomography (CT) imaging at the time of initial staging. We present a case of multiple metastatic papillary thyroid carcinoma whose radioiodine treatment response and clinical outcome were evaluated with F-fluorodeoxyglucose and Gallium-68 FAPI-04 positron emission tomography/CT.

摘要

一名50岁男性接受了全甲状腺切除术,组织病理学显示为甲状腺乳头状癌,肿瘤大小为4.5厘米。该患者被转诊至核医学诊所接受放射性碘治疗。由于治疗前甲状腺球蛋白水平为495μg/L,因此进行了低剂量(185MBq)的I-131扫描。在初始分期时,I-131全身扫描及单光子发射计算机断层扫描/计算机断层扫描(CT)成像显示,除了多发肝转移外,还在骶骨和右侧第7肋骨发现了骨转移。我们报告一例多发转移性甲状腺乳头状癌病例,其放射性碘治疗反应及临床结局通过F-氟脱氧葡萄糖和镓-68 FAPI-04正电子发射断层扫描/CT进行评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73d/9950682/6b5508039656/MIRT-32-57-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73d/9950682/daf86841516a/MIRT-32-57-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73d/9950682/f513e1bad82d/MIRT-32-57-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73d/9950682/83976f2621b1/MIRT-32-57-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73d/9950682/6b5508039656/MIRT-32-57-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73d/9950682/daf86841516a/MIRT-32-57-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73d/9950682/f513e1bad82d/MIRT-32-57-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73d/9950682/83976f2621b1/MIRT-32-57-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73d/9950682/6b5508039656/MIRT-32-57-g4.jpg

相似文献

1
Findings of I-131 SPECT/CT, F-FDG, and Ga-FAPI-04 PET/CT Imaging in a Patient Treated with Radioiodine Therapy for Metastatic Papillary Thyroid Carcinoma.131碘单光子发射计算机断层扫描/计算机断层扫描(I-131 SPECT/CT)、氟代脱氧葡萄糖(F-FDG)及镓标记的成纤维细胞激活蛋白抑制剂04正电子发射断层扫描/计算机断层扫描(Ga-FAPI-04 PET/CT)成像在接受放射性碘治疗的转移性乳头状甲状腺癌患者中的研究结果
Mol Imaging Radionucl Ther. 2023 Feb 23;32(1):57-61. doi: 10.4274/mirt.galenos.2022.02438.
2
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
3
Unilateral Chronic Parotitis With 68 Ga-DOTA-FAPI-04 PET/CT and 18 F-FDG PET/CT Imaging in a Case of a Patient With Papillary Thyroid Carcinoma.单侧慢性腮腺炎患者行 68Ga-DOTA-FAPI-04 PET/CT 和 18F-FDG PET/CT 成像:一例甲状腺乳头状癌病例报告
Clin Nucl Med. 2023 Dec 1;48(12):e577-e579. doi: 10.1097/RLU.0000000000004884. Epub 2023 Sep 23.
4
Ga-DOTA-RGD Positron Emission Tomography/Computed Tomography in Radioiodine Refractory Thyroid Cancer: Prospective Comparison of Diagnostic Accuracy with F-FDG Positron Emission Tomography/Computed Tomography and Evaluation Toward Potential Theranostics.镓-DOTA-RGD 正电子发射断层扫描/计算机断层扫描在放射性碘难治性甲状腺癌中的应用:与 F-FDG 正电子发射断层扫描/计算机断层扫描的诊断准确性的前瞻性比较及潜在治疗学评估。
Thyroid. 2020 Apr;30(4):557-567. doi: 10.1089/thy.2019.0450. Epub 2020 Jan 23.
5
Clinical utility of [Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma.镓[68Ga]标记成纤维细胞激活蛋白抑制剂(FAPI)正电子发射断层扫描/计算机断层扫描在鼻咽癌原发分期和复发检测中的临床应用。
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3606-3617. doi: 10.1007/s00259-021-05336-w. Epub 2021 Apr 1.
6
Accurate preoperative staging with [Ga]Ga-FAPI PET/CT for patients with oral squamous cell carcinoma: a comparison to 2-[F]FDG PET/CT.[Ga]Ga-FAPI PET/CT 对口腔鳞状细胞癌患者进行准确术前分期:与 2-[F]FDG PET/CT 的比较。
Eur Radiol. 2022 Sep;32(9):6070-6079. doi: 10.1007/s00330-022-08686-7. Epub 2022 Mar 30.
7
Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.甲状腺球蛋白、放射性碘成像及正电子发射断层扫描在甲状腺癌评估中的各自作用。
Semin Nucl Med. 2006 Jul;36(3):194-205. doi: 10.1053/j.semnuclmed.2006.03.002.
8
Positron emission tomography and computed tomography with [Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer.使用[镓]镓-成纤维细胞活化蛋白抑制剂的正电子发射断层扫描和计算机断层扫描可改善胰腺癌患者的肿瘤检测和分期。
Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1322-1337. doi: 10.1007/s00259-021-05576-w. Epub 2021 Oct 15.
9
68 Ga-FAPI-RGD PET/CT Detected Skull Metastasis Better Than 18 F-FDG in a Patient With Radioiodine-Refractory Differentiated Thyroid Cancer.68Ga-FAPI-RGD PET/CT 比 18F-FDG 更能检测放射性碘难治性分化型甲状腺癌患者的颅骨转移。
Clin Nucl Med. 2024 Oct 1;49(10):964-965. doi: 10.1097/RLU.0000000000005301. Epub 2024 May 31.
10
Evaluation of the usefulness of positron emission tomography with [18F]fluorodeoxylglucose performed to detect non-radioiodine avid recurrence and/or metastasis of differentiated thyroid cancer - a preliminary study.应用[18F]氟脱氧葡萄糖正电子发射断层扫描评估分化型甲状腺癌非放射性碘难治性复发和/或转移的价值 - 一项初步研究。
Nucl Med Rev Cent East Eur. 2021;24(2):63-69. doi: 10.5603/NMR.2021.0017.

引用本文的文献

1
[Ga]Ga-FAPI-04 PET/CT in the evaluation of radiation-induced salivary gland injury in head and neck cancer.[镓]镓-FAPI-04 PET/CT在评估头颈部癌放射性唾液腺损伤中的应用
Eur J Nucl Med Mol Imaging. 2025 Aug 12. doi: 10.1007/s00259-025-07486-7.
2
Diagnostic Performances of PET/CT Using Fibroblast Activation Protein Inhibitors in Patients with Primary and Metastatic Liver Tumors: A Comprehensive Literature Review.基于成纤维细胞激活蛋白抑制剂的 PET/CT 对原发性和转移性肝脏肿瘤患者的诊断性能:一项全面的文献综述。
Int J Mol Sci. 2024 Jun 29;25(13):7197. doi: 10.3390/ijms25137197.
3
Radiolabelled FGF-2 for Imaging Activated Fibroblasts in the Tumor Micro-Environment.

本文引用的文献

1
Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.镓-FAPI PET/CT:28 种不同癌症的示踪剂摄取。
J Nucl Med. 2019 Jun;60(6):801-805. doi: 10.2967/jnumed.119.227967. Epub 2019 Apr 6.
2
Rare metastases of well-differentiated thyroid cancers: a systematic review.高分化甲状腺癌的罕见转移:一项系统综述
Ann Surg Oncol. 2015 Feb;22(2):460-6. doi: 10.1245/s10434-014-4058-y. Epub 2014 Sep 6.
3
Diagnostic utility of PETCT in thyroid malignancies: an update.PETCT 在甲状腺恶性肿瘤中的诊断效用:更新。
用于肿瘤微环境中活化成纤维细胞成像的放射性标记成纤维细胞生长因子-2
Biomolecules. 2024 Apr 18;14(4):491. doi: 10.3390/biom14040491.
4
Advances in the Development of Positron Emission Tomography Tracers for Improved Detection of Differentiated Thyroid Cancer.用于改善分化型甲状腺癌检测的正电子发射断层显像示踪剂的研发进展
Cancers (Basel). 2024 Apr 2;16(7):1401. doi: 10.3390/cancers16071401.
5
FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature.基于FAPi的药物在甲状腺癌中的应用:迈向诊断与治疗的新进展?文献系统综述
Cancers (Basel). 2024 Feb 19;16(4):839. doi: 10.3390/cancers16040839.
6
Advancements in theranostic applications: exploring the role of fibroblast activation protein inhibition tracers in enhancing thyroid health assessment.治疗诊断应用的进展:探索成纤维细胞活化蛋白抑制示踪剂在增强甲状腺健康评估中的作用。
EJNMMI Res. 2023 Dec 22;13(1):109. doi: 10.1186/s13550-023-01060-8.
Ann Nucl Med. 2013 Oct;27(8):681-93. doi: 10.1007/s12149-013-0740-6. Epub 2013 Jun 26.
4
Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.甲状腺球蛋白抗体阳性对分化型甲状腺癌患者的影响:临床立场声明。
Thyroid. 2013 Oct;23(10):1211-25. doi: 10.1089/thy.2012.0606. Epub 2013 Aug 3.
5
Coexisting iodine avid and iodine nonconcentrating lesions with multiple distant soft tissue metastasis in papillary thyroid cancer.乳头状甲状腺癌中并存的摄碘性和非碘浓聚性病变伴多发远处软组织转移
Indian J Nucl Med. 2012 Jan;27(1):38-41. doi: 10.4103/0972-3919.108853.
6
18F-FDG PET/CT demonstration of a liver metastasis in a patient with papillary thyroid cancer.18F-FDG PET/CT 显示甲状腺乳头状癌患者的肝转移灶。
Clin Nucl Med. 2012 Sep;37(9):e234-6. doi: 10.1097/RLU.0b013e318262ae07.
7
Rare metastases of differentiated thyroid carcinoma: pictorial review.分化型甲状腺癌的罕见转移:影像学综述。
Endocr Relat Cancer. 2011 Aug 30;18(5):R165-74. doi: 10.1530/ERC-11-0068. Print 2011 Oct.
8
Utility of SPECT/CT as an adjunct to planar whole body I-131 imaging: liver metastasis from papillary thyroid cancer.SPECT/CT作为平面全身I-131成像辅助手段的效用:甲状腺乳头状癌肝转移
Clin Nucl Med. 2009 Apr;34(4):247-8. doi: 10.1097/RLU.0b013e31819a1eb3.